Antiviral Agents — Competitive Intelligence Brief

Antiviral Agents (Antiviral Agents) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiviral agent. Area: Infectious Disease.

phase 3 Antiviral agent Infectious Disease Small molecule

Target snapshot

Antiviral Agents (Antiviral Agents) — Pregistry. Antiviral agents work by inhibiting viral replication through various mechanisms such as blocking viral enzymes, preventing viral entry, or interfering with viral protein synthesis.

Comparator set (4 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Antiviral Agents TARGET	Antiviral Agents	Pregistry	phase 3	Antiviral agent
Docosanol 10%	Docosanol 10%	Hadassah Medical Organization	marketed	Antiviral agent	Viral membrane fusion machinery
Anti-HBV antiviral prophylaxis	Anti-HBV antiviral prophylaxis	Institut de Recherche pour le Developpement	phase 3	Antiviral agent
ACYC vehicle	ACYC vehicle	Bausch Health Americas, Inc.	phase 3	Antiviral agent (topical formulation)	Viral DNA polymerase (via acyclovir active ingredient)
Standard of Care Antiviral medications	Standard of Care Antiviral medications	New York Medical College	phase 3	Antiviral agent (class varies by specific drug)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiviral agent class)

1. Hadassah Medical Organization · 1 drug in this class
2. Institut de Recherche pour le Developpement · 1 drug in this class
3. Pregistry · 1 drug in this class